JO
ETTX

John Overdeck’s Entasis Therapeutics Holdings Inc. ETTX Stock Holding History

John Overdeck’s Portfolio ETTX Stock Details ETTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-99,542
Closed -$218K – 4768
2021
Q4 		$218K Sell
99,542
-86,688
-47% -$234K ﹤0.01% 3875
2021
Q3 		$622K Buy
186,230
+22,001
+13% +$59.7K ﹤0.01% 3057
2021
Q2 		$438K Buy
164,229
+124,868
+317% +$282K ﹤0.01% 3212
2021
Q1 		$84K Buy
39,361
+18,630
+90% +$52.9K ﹤0.01% 3715
2020
Q4 		$51K Buy
+20,731
New +$40.8K ﹤0.01% 3251

Other funds holding ETTX

TGA
TPG GP A Fort Worth, Texas $5B AUM 58.56% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $7.48B AUM 104.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $5.69B AUM 60.64% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
GF
Gabelli Funds Rye, New York $15.7B AUM 36.4% 1-Year Est. Return
Janney Montgomery Scott
Janney Montgomery Scott Philadelphia, Pennsylvania $51.6B AUM 27.34% 1-Year Est. Return
DMKJ
David M. Knott Jr $189M AUM 67.72% 1-Year Est. Return

John Overdeck's ETTX Position: Q1 2022 in Review

John Overdeck sold out of Entasis Therapeutics Holdings Inc. (ETTX) in Q1 2022, closing a stake of 99,542 shares — an estimated $218K sold.

John Overdeck first reported a position in ETTX in Q4 2020 and held it in 5 quarters. The position peaked at $622K in Q3 2021. 22 funds tracked by Wall St. Rank hold ETTX as of Q1 2022.

  • John Overdeck reported no remaining Entasis Therapeutics Holdings Inc. position as of Q1 2022 after selling out during the quarter.
  • John Overdeck sold 99,542 Entasis Therapeutics Holdings Inc. shares in Q1 2022, an estimated $218K.
  • John Overdeck first reported a position in Entasis Therapeutics Holdings Inc. in Q4 2020 and held it in 5 quarters.
  • John Overdeck's Entasis Therapeutics Holdings Inc. position peaked at $622K in Q3 2021.
  • 22 funds tracked by Wall St. Rank held Entasis Therapeutics Holdings Inc. as of Q1 2022.

Based on Two Sigma Investments's 13F filing for Q1 2022, filed 16 May 2022.